Globus Medical's Secure-C Cervical Artificial Disc was granted expanded coverage by Anthem.
Three things to know:
1. The FDA approved the cervical artificial disc in 2012. Globus Medical designed the disc for reconstruction and motion perseveration at the operated disc level.
2. Globus Medical published a long term, seven-year clinical trial in the International Journal of Spine Surgery outlining the success of the Secure-C compared to traditional anterior cervical discectomy and fusion.
3. At seven-year post-operative follow-up, patients treated with Secure-C exhibited the following results compared to patients treated with ACDF:
• Statistically superior composite protocol-specified overall success results (86.3 percent vs. 70 percent)
• Statistically superior composite FDA-defined overall success results (79.2 percent vs. 63.6 percent)
• Greater percentage of patients with at least 25 percent improvement in Neck Disability Index (90.4 percent vs. 86 percent)
• Lower rate of subsequent surgery at the original treated level (4.2 percent vs. 15.3 percent)
• Lower rate of adjacent level surgery (4.2 percent vs. 16 percent)